Unknown NA INTERVENTIONAL 1-arm NCT02752503

Nalmefene in Alcohol Dependence and Borderline Personality Disorder

Open-label Trial on Therapeutic Effect and Tolerability of Nalmefene in Subjects With Alcohol Use Disorder and Comorbid Borderline Personality Disorder

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Conditions Alcohol Use Disorder Borderline Personality Disorder

Interventions Nalmefene

Updated 6 times since 2017 Last updated: Apr 22, 2016 Started: Mar 31, 2015 Primary completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alcohol Use Disorder and Borderline Personality Disorder and is currently ongoing. Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
May 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — May 2018 [monthly]

Recruiting NA

First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Hospital Universitari General de Catalunya

Data source: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain